Noxilizer Inc. specializes in providing ultra-low temperature nitrogen dioxide (NO₂) terminal sterilization solutions for the pharmaceutical, biotechnology, and medical device industries. Their platform offers a validated, safe, and scalable alternative to traditional sterilization methods, such as ethylene oxide, and is compatible with sensitive biologics and drug-device combinations. Headquartered in Hanover, Maryland, Noxilizer supports its clients with R&D studies, packaging and design consulting, validation, and technical support, leveraging its proprietary sterilization equipment and consumables.